Results 131 to 140 of about 511,985 (313)

Participatory action research to pilot a model of mental health service user involvement in an Ethiopian rural primary healthcare setting: study protocol [PDF]

, 2020
Sisay Abayneh, Heidi Lempp, Charlotte Hanlon   +2 more
openalex   +1 more source

Participatory Action Research for Dealing with Disasters on Islands [PDF]

Much disaster research has a basis in non-island case studies, although mono-disciplinary disaster-related research across past decades has often used case studies of individual islands.
Ilan Kelman, James Lewis, JC Gaillard, Jessica Mercer   +3 more
core  

Feasibility of a ctDNA multigenic panel for non‐small‐cell lung cancer early detection and disease surveillance

Molecular Oncology, EarlyView.
Plasma‐based detection of actionable mutations is a promising approach in lung cancer management. Analysis of ctDNA with a multigene NGS panel identified TP53, KRAS, and EGFR as the most frequently altered, with TP53 and KRAS in treatment‐naïve patients and TP53 and EGFR in previously treated patients.
Giovanna Maria Stanfoca Casagrande, Marcela de Oliveira Silva, Mariana Bisarro dos Reis, Rodrigo de Oliveira Cavagna, Luciane Sussuchi, Icaro Alves Pinto, Natalia Zampieri Pontes, Rodrigo Sampaio Chiarantano, Flavio Augusto Ferreira da Silva, Pedro de Marchi, Letícia Ferro Leal, Rui M. Reis   +11 more
wiley   +1 more source

PARTICIPATORY ACTION RESEARCH

Sosio Informa, 2005
Sebuah Kerangka Kerja bagi Action Research dalam Pengembangan Komunitas dan Pendidikan Populer - This paper helps to elaborate about how researchers, teachers and educational advisors balance their different roles in participatory action research teams.
openaire   +2 more sources

“From Where I Sit”: Filipino Youth, Sexuality and Immigration in Participatory Action Research [PDF]

, 2010
Studies of young people\u27s experiences of sexuality rarely discuss how immigration and settlement impact youths\u27 understanding of their bodies, sexual identities, and knowledge.
Francisco, Valerie
core   +1 more source

Glycosylated LGALS3BP is highly secreted by bladder cancer cells and represents a novel urinary disease biomarker

Molecular Oncology, EarlyView.
Urinary LGALS3BP is elevated in bladder cancer patients compared to healthy controls as detected by the 1959 antibody–based ELISA. The antibody shows enhanced reactivity to the high‐mannose glycosylated variant secreted by cancer cells treated with kifunensine (KIF).
Asia Pece, Giulio Lovato, Ilaria Cela, Arianna Mercatelli, Benedetta Ferro, Jussi Nikkola, Sara Pagotto, Tommaso Grottola, Vincenzo De Laurenzi, Rossella Cicchetti, Antonio Marchetti, Luigi Schips, Rossano Lattanzio, Stefano Iacobelli, Emily Capone, Peter Black, Mads Daugaard, Michele Marchioni, Gianluca Sala   +18 more
wiley   +1 more source

Reduced vascular leakage correlates with breast carcinoma T regulatory cell infiltration but not with metastatic propensity

Molecular Oncology, EarlyView.
A mouse model for vascular normalization and a human breast cancer cohort were studied to understand the relationship between vascular leakage and tumor immune suppression. For this, endothelial and immune cell RNAseq, staining for vascular function, and immune cell profiling were employed.
Liqun He, Chiara Testini, Neda Hekmati, Altea Bonello, Aglaia Schiza, Emmanuel Nwadozi, Mia Phillipson, Carina Strell, Michael Welsh   +8 more
wiley   +1 more source

Participatory Action Research: Engaging Communities in Mental Health

MedUNAB
As we usher in the new year, it presents a valuable opportunity for introspection and forward-looking aspiration an invitation to envision a future enriched with hope and an improved quality of life. While personal reflections often take center stage, it
Sandra Janashak, Cadena
doaj   +1 more source

Improving PARP inhibitor efficacy in bladder cancer without genetic BRCAness by combination with PLX51107

Molecular Oncology, EarlyView.
Clinical trials on PARP inhibitors in urothelial carcinoma (UC) showed limited efficacy and a lack of predictive biomarkers. We propose SLFN5, SLFN11, and OAS1 as UC‐specific response predictors. We suggest Talazoparib as the better PARP inhibitor for UC than Olaparib.
Jutta Schmitz, Anna L. Bartkowiak, Michael Rose, Nora Kolks, Patrick Petzsch, Vandana Solanki, Anne Stoffel, Bianca Faßbender, Leandra Lepping, Julka Volkamer, Karl Köhrer, Marc Seifert, Tokameh Mahmoudi, Tahlita C. M. Zuiverloon, Günter Niegisch, Michèle J. Hoffmann   +15 more
wiley   +1 more source

Participatory science in action: Transforming urban soil research

iScience
Anna Paltseva, PhD, is an urban soil scientist committed to improving soil health in city environments through research and community collaboration. Her work in New York City and Lafayette, Louisiana, demonstrates the power of participatory science to ...
Anna Paltseva
doaj   +1 more source